Pharmaceuticals
-
Antibiotic link to female heart disease
Middle-aged and elderly women who take antibiotics for extended periods face increased risk of suffering cardiovascular events, researchers warned today. Read more
-
Abandoned diabetes drug shows lymphoma promise
A drug abandoned as a treatment for diabetes may protect against the development of T-cell lymphoma, Scottish researchers have reported. Read more
-
Statins failing half of patients but do they take them?
Half of patients prescribed statins do not achieve the necessary “healthy” cholesterol levels after two years of treatment, according to a new observational study. Read more
-
Diabetes drug protects against kidney disease
A drug developed to help people with diabetes has been found to reduce heart failure, major cardiovascular events and protect against kidney failure. Read more
-
Immunotherapy questioned for the elderly
Immunotherapy is less effective for elderly patients with non-small-cell lung cancer than with younger patients, a conference will hear today. Read more
-
Drugs used to enhance sexual experiences, especially in UK
People in the UK are more likely to combine drugs with sex than those living in other countries, researchers report today. Read more
-
Preventative drugs provide little benefit to some patients
Reducing the use of preventive medications in people with advanced cancer near the end of life could reduce unnecessary side effects and improve patient quality of life, a new study has found. Read more
-
Drug that could tackle bowel cancer drug-resistance
British scientists have identified a third drug that could help tackle resistance to treatment when bowel cancer is treated with the latest therapies, it was announced today. Read more
-
Success against TB – but resistance still a concern
The number of new TB diagnoses in England has nearly halved this decade – but scientists have warned of the continuing threat from antibiotic resistance. Read more
-
Tuberculosis-linked infection measured
Doctors should look for fungal infections when treating TB, researchers have warned. Read more
